Background—Patients surviving ventricular fibrillation (VF) or sustained ventricular
tachycardia (VT) are at a high risk of death due to a recurrence of arrhythmia. The implantable …

Background It is common practice to restore and maintain sinus rhythm in patients with atrial
fibrillation and heart failure. This approach is based in part on data indicating that atrial …

Background Implantable cardioverter–defibrillator (ICD) therapy has been shown to
improve survival in patients with various heart conditions who are at high risk for ventricular …

Background The restoration and maintenance of sinus rhythm is a desirable goal in patients
with atrial fibrillation, because the prevention of recurrences can improve cardiac function …

Background Atrial fibrillation is a leading preventable cause of recurrent stroke for which
early detection and treatment are critical. However, paroxysmal atrial fibrillation is often …

Background Lidocaine has been the initial antiarrhythmic drug treatment recommended for
patients with ventricular fibrillation that is resistant to conversion by defibrillator shocks. We …

The Canadian Cardiovascular Society (CCS) atrial fibrillation (AF) guidelines program was
developed to aid clinicians in the management of these complex patients, as well as to …

ContextImplantable cardioverter defibrillator (ICD) therapy is effective but is associated with
high-voltage shocks that are painful.ObjectiveTo determine whether amiodarone plus β-…

ContextFew randomized controlled trials have evaluated the efficacy of treatments for major
depression in patients with coronary artery disease (CAD). None have simultaneously …

OBJECTIVES We sought to assess the impact of intermittent atrial fibrillation (AF) on health-related
quality of life (QoL). BACKGROUND Intermittent AF is a common condition with little …